Molecular prediction for atherogenic risks across different cell types of leukocytes

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Cheng, Feng ^a   Keeley, Ellen C ^b   Lee, Jae K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL TYPE; FAMILIAL HYPERLIPEMIA; GENE EXPRESSION; HUMAN; LEUKOCYTE; MACROPHAGE; MONOCYTE; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE; BLOOD; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; RISK;

ALGORITHMS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; RISK;

EID: 84862801746     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-2     Document Type: Article

References (19)

1. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, et al. Circulation 2000 102 25 3137 3147 11120707
2. Biomarkers of premature atherosclerosis. Kampoli AM, Tousoulis D, Antoniades C, Siasos G, Stefanadis C, Trends Mol Med 2009 15 7 323 332 10.1016/j.molmed.2009.06.001 19577961
3. Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential. Tertov VV, Kaplun VV, Orekhov AN, Biofactors 1997 6 2 139 143 10.1002/biof.5520060207 9259995 (Pubitemid 27487818)
4. Pathway analysis of coronary atherosclerosis. King JY, Ferrara R, Tabibiazar R, Spin JM, Chen MM, Kuchinsky A, Vailaya A, Kincaid R, Tsalenko A, Deng DX, et al. Physiol Genomics 2005 23 1 103 118 10.1152/physiolgenomics. 00101.2005 15942018
5. Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries. Cagnin S, Biscuola M, Patuzzo C, Trabetti E, Pasquali A, Laveder P, Faggian G, Iafrancesco M, Mazzucco A, Pignatti PF, et al. BMC Genomics 2009 10 13 10.1186/1471-2164-10-13 19134193
6. Diagnosis of atherosclerosis by imaging. Ibanez B, Badimon JJ, Garcia MJ, Am J Med 2009 122 1 Suppl 15 25 19110084
7. CT-Based coronary angiography. Rensing BJ, Surruys PW, de Feyter PJ, J Invasive Cardiol 2000 12 1 23 24 10731259
8. Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism. Mosig S, Rennert K, Buttner P, Krause S, Lutjohann D, Soufi M, Heller R, Funke H, BMC Med Genomics 2008 1 60 10.1186/1755-8794-1-60 19040724
9. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Marks D, Thorogood M, Neil HA, Humphries SE, Atherosclerosis 2003 168 1 1 14 10.1016/S0021-9150(02)00330-1 12732381 (Pubitemid 36559596)
10. Expression profiling of macrophages from subjects with atherosclerosis to identify novel susceptibility genes. Hagg DA, Jernas M, Wiklund O, Thelle DS, Fagerberg B, Eriksson P, Hamsten A, Olsson B, Carlsson B, Carlsson LM, et al. Int J Mol Med 2008 21 6 697 704 18506362
11. Statistical significance for genomewide studies. Storey JD, Tibshirani R, Proc Natl Acad Sci USA 2003 100 16 9440 9445 10.1073/pnas.1530509100 12883005 (Pubitemid 37033947)
12. Pharmacotherapy of coronary atherosclerosis. Finn AV, Kramer MC, Vorpahl M, Kolodgie FD, Virmani R, Expert Opin Pharmacother 2009 10 10 1587 1603 10.1517/14656560902988494 19527187
13. Inflammation in atherosclerosis: from pathophysiology to practice. Libby P, Ridker PM, Hansson GK, J Am Coll Cardiol 2009 54 23 2129 2138 10.1016/j.jacc.2009.09.009 19942084
14. Index for rating diagnostic tests. Youden WJ, Cancer 1950 3 1 32 35 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 15405679
15. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Lee JK, Havaleshko DM, Cho H, Weinstein JN, Kaldjian EP, Karpovich J, Grimshaw A, Theodorescu D, Proc Natl Acad Sci USA 2007 104 32 13086 13091 10.1073/pnas.0610292104 17666531 (Pubitemid 351737597)
16. Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy. Williams PD, Cheon S, Havaleshko DM, Jeong H, Cheng F, Theodorescu D, Lee JK, Cancer Res 2009 69 21 8302 8309 10.1158/0008-5472.CAN-09-0798 19843853
17. Mobilization of pro-inflammatory lipids in obese Plscr3-deficient mice. Mutch DM, O'Maille G, Wikoff WR, Wiedmer T, Sims PJ, Siuzdak G, Genome Biol 2007 8 3 38 10.1186/gb-2007-8-3-r38 17355638 (Pubitemid 351851051)
18. The in and out of monocytes in atherosclerotic plaques: Balancing inflammation through migration. Ludewig B, Laman JD, Proc Natl Acad Sci USA 2004 101 32 11529 11530 10.1073/pnas.0404612101 15292506 (Pubitemid 39095329)
19. Coronary artery disease: Are men and women created equal? Blum A, Blum N, Gend Med 2009 6 3 410 418 10.1016/j.genm.2009.09.005 19850237